Insulet Q4 Earnings Review: Strong Performance Meets Sky-High Expectations

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?It has been some time since I last posted about Insulet Corporation ( PODD ) for Seeking Alpha. My last coverage was in November 2024, and I assigned the stock a Hold rating. That seems toEdmund Ingham is a biotech ...